EXPEDITION MEDICINES Trademark
Trademark Overview
On Tuesday, March 4, 2025, a trademark application was filed for EXPEDITION MEDICINES with the United States Patent and Trademark Office. The USPTO has given the EXPEDITION MEDICINES trademark a serial number of 99975230. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Friday, May 22, 2026. This trademark is owned by Expedition Medicines, Inc.. The EXPEDITION MEDICINES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals for the treatment, prevention, mitigation, and management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, and management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; small molecule therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, or management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; small molecule pharmaceuticals for the treatment, prevention, mitigation, or management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune...
Scientific research, namely, research and analysis services for the design and characterization of chemical therapeutic products; research services in the fields of proteomic analysis; proteomic analysis for scientific and research purposes; medical and scientific research in the field of proteomics; research and development in the field of proteomics; medical research, namely, compiling data for research purposes in the field of proteomics
General Information
| Serial Number | 99975230 |
| Word Mark | EXPEDITION MEDICINES |
| Filing Date | Tuesday, March 4, 2025 |
| Status | 748 - STATEMENT OF USE - TO EXAMINER |
| Status Date | Friday, May 22, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 16, 2025 |
Trademark Statements
| NOT AVAILABLE | "MEDICINES" |
| Goods and Services | Pharmaceuticals for the treatment, prevention, mitigation, and management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, and management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; small molecule therapeutics, namely, therapeutic agents for the treatment, prevention, mitigation, or management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders; small molecule pharmaceuticals for the treatment, prevention, mitigation, or management of cancer, genitourinary, oncological, respiratory, gastrointestinal, dermatological, immune system-related, autoimmune, rheumatological, and age-related diseases and disorders |
| Goods and Services | Scientific research, namely, research and analysis services for the design and characterization of chemical therapeutic products; research services in the fields of proteomic analysis; proteomic analysis for scientific and research purposes; medical and scientific research in the field of proteomics; research and development in the field of proteomics; medical research, namely, compiling data for research purposes in the field of proteomics |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 4, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, May 26, 2025 |
| First Use In Commerce Date | Monday, May 26, 2025 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 4, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, October 22, 2025 |
| First Use In Commerce Date | Wednesday, October 22, 2025 |
Trademark Owner History
| Party Name | Expedition Medicines, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142
US |
| Party Name | Expedition Medicines, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142
US |
Trademark Events
| Event Date | Event Description |
| Tuesday, March 4, 2025 | NEW APPLICATION ENTERED |
| Tuesday, March 4, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, July 24, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 6, 2025 | ASSIGNED TO EXAMINER |
| Friday, August 8, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, August 8, 2025 | NON-FINAL ACTION E-MAILED |
| Friday, August 8, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, August 19, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, August 19, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 19, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 20, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 10, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, September 16, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 16, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 11, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, December 11, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, December 11, 2025 | SOU EXTENSION 1 FILED |
| Thursday, December 11, 2025 | SOU EXTENSION 1 GRANTED |
| Thursday, December 11, 2025 | TEAS STATEMENT OF USE RECEIVED |
| Friday, December 12, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Saturday, May 2, 2026 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, December 11, 2025 | TEAS REQUEST TO DIVIDE RECEIVED |
| Thursday, December 11, 2025 | DIVISIONAL REQUEST RECEIVED |
| Friday, May 22, 2026 | DIVISIONAL PROCESSING COMPLETE |
| Wednesday, December 10, 2025 | SOU EXTENSION 2 FILED |
| Friday, May 22, 2026 | SOU EXTENSION 2 GRANTED |
| Thursday, December 11, 2025 | USE AMENDMENT FILED |
| Friday, May 22, 2026 | STATEMENT OF USE PROCESSING COMPLETE |
| Saturday, May 23, 2026 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
